Form 4: Estee Lauder Director Granted Stock Options, Units

Sentiment:

Insider Transaction Disclosure


Jennifer Tejada, a director at Estee Lauder Companies Inc., was granted 2,780 stock options and 783.28 stock units on November 13, 2025, as part of the company's non-employee director incentive plan.

Summary

  • Jennifer Tejada, a director of Estee Lauder Companies Inc. (EL), acquired derivative securities on November 13, 2025.
  • She was granted 2,780 stock options with an exercise price of $89.92 per share. These options become exercisable on November 13, 2026, and expire on November 13, 2035.
  • Additionally, Tejada received 783.28 stock units, each convertible into one share of Class A Common Stock.
  • These grants were made under the Issuer's Amended and Restated Non-Employee Director Share Incentive Plan.
  • Following these transactions, Tejada beneficially owns 2,780 stock options and 4,361.08 stock units directly.
  • The stock units will be paid out on the first business day of the calendar year following the last date of her service as a director.
  • The transaction was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. This is a routine disclosure of director compensation, which is a positive for aligning interests but doesn't indicate significant operational news. The grants are part of an established plan.

Positives

  • The grant of stock options and units aligns the director's interests with those of shareholders, incentivizing long-term company performance.
  • The transaction is part of a pre-arranged Rule 10b5-1 plan, indicating a structured approach to equity compensation.

Future Outlook

The stock options granted will become exercisable on November 13, 2026, and the stock units will be paid out on the first business day of the calendar year following the director's departure from service.

Industry Context

This filing reflects standard equity compensation practices for non-employee directors in publicly traded companies, aiming to align leadership incentives with long-term shareholder value creation. Such grants are common across the consumer goods and beauty industry for attracting and retaining experienced board members.

Comparison to Industry Standards

  • Equity compensation for non-employee directors, including stock options and restricted stock units, is a common practice across S&P 500 companies, similar to peers like L'Oréal or Procter & Gamble.
  • The use of a Rule 10b5-1 plan for these transactions is a standard corporate governance practice to mitigate insider trading concerns and provide an affirmative defense.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Compensation Plan UtilizationGrants made pursuant to the Issuer's Amended and Restated Non-Employee Director Share Incentive Plan, demonstrating ongoing use of established compensation frameworks.11/13/2025Reinforces alignment of director incentives with shareholder interests and adherence to a pre-approved compensation structure.
Insider Trading Policy AdherenceTransaction made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged schedule for equity transactions.11/13/2025Enhances transparency and provides an affirmative defense against insider trading allegations, reflecting sound corporate governance.

Stakeholder Impact

  • Shareholders: Positive impact due to increased alignment of director incentives with long-term company performance and shareholder value.

Next Steps

  • The stock options will become exercisable on November 13, 2026.
  • The stock units will be paid out on the first business day of the calendar year following Jennifer Tejada's last date of service as a director.

Key Dates

DateDescription
11/13/2025Date of earliest transaction for stock option and stock unit grants.
11/14/2025Signature date of the reporting person's attorney-in-fact.
11/13/2026Date when the granted stock options become exercisable.
11/13/2035Expiration date of the granted stock options.
First business day of the calendar year following the last date of the Reporting Person's service as a directorPayout date for the stock units.

Recommendation

hold

This Form 4 filing details routine equity compensation for a non-employee director, which is a standard practice to align management incentives with shareholder interests. It does not contain any new operational, financial, or strategic information that would warrant a change in investment recommendation. The transaction is expected and reflects normal course of business for director compensation.

Keywords

Estee Lauder, EL, Jennifer Tejada, Form 4, Stock Options, Stock Units, Director Compensation, Equity Grant, Rule 10b5-1, Insider Transaction

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.